Total planned funding: $1,034,636,989
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $317,485,595 |
Tanzania | $133,127,211 |
Kenya | $93,473,975 |
Uganda | $91,045,294 |
Nigeria | $78,019,095 |
Zimbabwe | $55,871,779 |
Mozambique | $43,830,625 |
Zambia | $31,987,916 |
Haiti | $26,439,157 |
Malawi | $21,169,175 |
Ethiopia | $18,881,228 |
Cameroon | $16,533,704 |
Botswana | $14,656,119 |
Namibia | $12,523,118 |
Democratic Republic of the Congo | $10,993,746 |
Burundi | $10,140,422 |
Lesotho | $9,249,958 |
Vietnam | $7,908,455 |
Ukraine | $5,653,093 |
Eswatini | $5,484,149 |
Côte d'Ivoire | $5,369,133 |
Cambodia | $4,659,203 |
Ghana | $4,375,000 |
Rwanda | $4,275,966 |
Central Asia Region | $3,800,000 |
India | $2,850,000 |
South Sudan | $2,227,942 |
Central America Region | $2,080,931 |
Angola | $375,000 |
Caribbean Region | $150,000 |
Indonesia | $0 |
Asia Regional Program | $0 |
Program Areas
Treatment | $361,448,025 |
Care | $255,391,131 |
Prevention | $207,593,449 |
Governance and Systems | $126,573,424 |
Testing | $97,829,073 |
Budget Codes
HTXS: Treatment: Adult Treatment | $273,271,081 |
HKID: Care: Orphans and Vulnerable Children | $130,437,163 |
HVCT: Testing: HIV Testing and Counseling | $97,829,073 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $73,417,828 |
HVOP: Sexual Prevention: Other Sexual Prevention | $68,679,267 |
HBHC: Care: Adult Care and Support | $65,274,442 |
HVSI: Strategic Information | $59,544,836 |
HTXD: Treatment: ARV Drugs | $53,268,973 |
OHSS: Health Systems Strengthening | $44,631,043 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $43,117,596 |
HVTB: Care: TB/HIV | $41,835,392 |
PDTX: Treatment: Pediatric Treatment | $34,907,971 |
HLAB: Laboratory Infrastructure | $22,397,545 |
PDCS: Care: Pediatric Care and Support | $17,844,134 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,552,505 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,278,940 |
HMBL: Biomedical Prevention: Blood Safety | $1,500,000 |
HMIN: Biomedical Prevention: Injection Safety | $47,313 |